These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 25264001)
1. [Early diagnosis of hepatocellular carcinoma]. Mao Y; Xu H Zhonghua Nei Ke Za Zhi; 2014 Jul; 53(7):508-10. PubMed ID: 25264001 [No Abstract] [Full Text] [Related]
3. State of the art: hepatocellular carcinoma. Bolondi L Future Oncol; 2014 Nov; 10(15 Suppl):1-6. PubMed ID: 25478759 [No Abstract] [Full Text] [Related]
4. Early hepatocellular carcinoma - is there such a thing as too early? McCaughan GW J Hepatol; 2013 Feb; 58(2):210-1. PubMed ID: 23159769 [No Abstract] [Full Text] [Related]
5. Screening for hepatocellular carcinoma in chronic liver disease. Kansagara D; Papak J; Jou JH Ann Intern Med; 2015 Feb; 162(3):240. PubMed ID: 25643314 [No Abstract] [Full Text] [Related]
6. Screening for hepatocellular carcinoma in chronic liver disease. Giannini EG; Trevisani F Ann Intern Med; 2015 Feb; 162(3):239-40. PubMed ID: 25643313 [No Abstract] [Full Text] [Related]
7. Screening for hepatocellular carcinoma in chronic liver disease. Chirovsky D; Lich KH; Barritt AS Ann Intern Med; 2015 Feb; 162(3):238-9. PubMed ID: 25643312 [No Abstract] [Full Text] [Related]
8. "Wait and see" policy for early hepatocellular carcinoma. Francica G; de Sio I; Pompili M; Livraghi T J Hepatol; 2013 Sep; 59(3):635-6. PubMed ID: 23727237 [No Abstract] [Full Text] [Related]
9. Reply to: ""wait and see" policy for early hepatocellular carcinoma". Midorikawa Y; Takayama T J Hepatol; 2013 Sep; 59(3):636-7. PubMed ID: 23727235 [No Abstract] [Full Text] [Related]
10. Evidence is weak to support hepatocellular carcinoma screening in chronic liver disease. Taylor-Robinson SD; Wong J; Crossey MM; Khan SA Evid Based Med; 2015 Apr; 20(2):59. PubMed ID: 25694341 [No Abstract] [Full Text] [Related]
11. Hepatocellular carcinoma tumour markers: current role and expectations. Rich N; Singal AG Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):843-53. PubMed ID: 25260312 [TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma surveillance in patients with alcoholic cirrhosis. Jepsen P; Ott P Expert Rev Gastroenterol Hepatol; 2012 Dec; 6(6):651-3. PubMed ID: 23237248 [No Abstract] [Full Text] [Related]
13. Do patients screened for hepatocellular carcinoma die significantly older? Braillon A Gut; 2011 Jul; 60(7):1024. PubMed ID: 21427199 [No Abstract] [Full Text] [Related]
14. Serum TGF-β1: A Potential Biomarker for Early Detection of Hepatocellular Carcinoma. He J; Liu Y EBioMedicine; 2016 Oct; 12():4-5. PubMed ID: 27665049 [No Abstract] [Full Text] [Related]
15. Surveillance for hepatocellular carcinoma: evidence, guidelines and utilization. Shoreibah MG; Bloomer JR; McGuire BM; Massoud OI Am J Med Sci; 2014 May; 347(5):415-9. PubMed ID: 24759379 [No Abstract] [Full Text] [Related]
17. Serum Golgi Phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma. Li X; Wu K; Fan D Hepatology; 2009 Jul; 50(1):325. PubMed ID: 19492428 [No Abstract] [Full Text] [Related]
18. Acting in the face of uncertainty. Atkins D; Ross D; Kelley M Ann Intern Med; 2014 Aug; 161(4):300-1. PubMed ID: 24934826 [No Abstract] [Full Text] [Related]
19. Surveillance for hepatocellular carcinoma: can we focus on the mission? Kanwal F; El-Serag HB; Ross D Clin Gastroenterol Hepatol; 2015 Apr; 13(4):805-7. PubMed ID: 25541193 [No Abstract] [Full Text] [Related]
20. α-Fetoprotein in hepatocellular carcinoma surveillance: mend it but do not end it. El-Serag HB; Kanwal F Clin Gastroenterol Hepatol; 2013 Apr; 11(4):441-3. PubMed ID: 23376321 [No Abstract] [Full Text] [Related] [Next] [New Search]